The direct vasomotor effect of thyroid hormones on rat muscle resistance arteries

Anesthesia and Analgesia

Volumn 85, Issue 4, 1997, Pages 734-738

  Park, Kyung W ^a,c   Dai, Hai B ^a   Ojamaa, Kaie ^b   Lowenstein, Edward ^a   Klein, Irwin ^b   Sellke, Frank W ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; GLIBENCLAMIDE; INDOMETACIN; LIOTHYRONINE; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; POTASSIUM CHANNEL BLOCKING AGENT; PROPRANOLOL; PROSTAGLANDIN SYNTHASE INHIBITOR; THROMBOXANE RECEPTOR STIMULATING AGENT; THYROXINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HORMONE ACTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKELETAL MUSCLE; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASODILATATION;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; ENDOTHELIUM, VASCULAR; FEMALE; MALE; MUSCLE, SKELETAL; PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC; RATS; RATS, WISTAR; THROMBOXANE A2; THYROID HORMONES; VASCULAR RESISTANCE; VASODILATION;

EID: 0030871067     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199710000-00005     Document Type: Article

References (29)

1. Klein I. Thyroid hormone and the cardiovascular system. Am J Med 1990;88:631-7.
2. Klemperer JD, Ojamaa K, Klein I. Thyroid hormone therapy in cardiovascular disease. Prog Cardiovasc Dis 1996;38:329-36.
3. Salter DR, Dyke CM, Wechsler AS. Triiodothyronine (T3) and cardiovascular therapeutics: a review. J Cardiac Surg 1992;7: 363-74.
4. Novitzky D, Cooper DKC, Chaffin JS, et al. Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient. Transplantation 1990;49:311-6.
5. Jeevanandam V, Todd B, Regillo T, et al. Reversal of donor myocardial dysfunction by triiodothyronine replacement therapy. J Heart Lung Transplant 1994;13:681-7.
6. Novitzky D, Human PA, Cooper DKC. Inotropic effect of triiodothyronine following myocardial ischemia and cardiopulmonary bypass: an experimental study in pigs. Ann Thorac Surg 1988;45:50-5.
7. Klemperer JD, Zelano J, Helm RE, et al. Triiodothyronine improves left ventricular function without oxygen wasting after global hypothermic ischemia. J Thorac Cardiovasc Surg 1995; 109:457-65.
8. Novitzky D, Cooper DKC, Barton CI, et al. Triiodothyronine as an inotropic agent after open heart surgery. J Thorac Cardiovasc Surg 1989;98:972-8.
9. Teiger E, Menasche P, Mansier P, et al. Triiodothyronine therapy in open-heart surgery: from hope to disappointment. Eur Heart J 1993;14:629-33.
10. Klemperer JD, Klein I, Gomez M, et al. Thyroid hormone treatment after coronary artery bypass surgery. N Engl J Med 1995; 333:1522-7.
11. Bennett-Guerrero E, Jimenez JL, White WD, et al. Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery. JAMA 1996;275:687-92.
12. Burman KD. Is triiodothyronine administration beneficial in patients undergoing coronary artery bypass surgery? [editorial]. JAMA 1996;275:723-4.
13. Utiger RD. Altered thyroid function in nonthyroidal illness and surgery: to treat or not to treat? [editorial]. N Engl J Med 1995;333:1562-3.
14. Dyke AM, Ding M, Abd-Elfattah AS, et al. Effects of triiodothyronine supplementation after myocardial ischemia. Ann Thorac Surg 1993;56:215-22.
15. DiPierro FV, Bavaria JE, Lankford EB, et al. Triiodothyronine optimizes sheep ventriculoarterial coupling for work efficiency. Ann Thorac Surg 1996;62:662-9.
16. Ririe DG, Butterworth JF IV, Royster RL, et al. Triiodothyronine increases contractility independent of β-adrenergic receptors or stimulation of cyclic-3′,5′-adenosine monophosphate. Anesthesiology 1995;82:1004-12.
17. Walker JD, Crawford FA, Spinale FG. Pretreatment with 3,5,3′triiodo-L-thyronine (T3): effects on myocyte contractile function after hypothermic cardioplegic arrest and rewarming. J Thorac Cardiovasc Surg 1995;110:315-27.
18. Ott RA, Gutfinger DE, Miller MP, et al. Rapid recovery after coronary artery bypass grafting: is the elderly patient eligible? Ann Thorac Surg 1997;63:634-9.
19. Cimochowski GE, Harostock MD, Foldes PJ. Minimal operative mortality in patients undergoing coronary artery bypass with significant left ventricular dysfunction by maximization of metabolic and mechanical support. J Thorac Cardiovasc Surg 1997; 113:655-66.
20. Ojamaa K, Klemperer JD, Klein IL. Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 1996;6:505-12.
21. Park KW, Dai HB, Lowenstein E, et al. Heterogeneous vasomotor effect of isoflurane on rabbit coronary microvessels. Anesthesiology 1994;81:1190-7.
22. Park KW, Dai HB, Lowenstein E, Sellke FW. Vasomotor responses of rat coronary arteries to isoflurane and halothane depend on pre-exposure tone and vessel size. Anesthesiology 1995;82:1323-30.
23. ω-nitro-L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation. Eur J Pharmacol 1990;176:219-23.
24. Toda H, Nakamura K, Hatano Y, et al. Halothane and isoflurane inhibit endothelium-dependent relaxation elicited by acetylcholine. Anesth Analg 1992;75:198-203.
25. ATP channel inhibition [abstract]. Anesthesiology 1995;83:A603.
26. Ishikawa T, Chjiwa T, Hagiwara M, et al. Thyroid hormones directly interact with vascular muscle strips. Mol Pharmacol 1985;35:760-5.
27. De Nucci G, Gryglewski RJ, Warner TD, Vane JR. Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled. Proc Natl Acad Sci USA 1988;85:2334-8.
28. Chen G, Suzuki H. Some electrical properties of the endothelium-dependent hyperpolarization recorded from rat arterial smooth muscle cells. J Physiol 1989;410:91-106.
29. + channels in arterial smooth muscle. Science 1989;245:177-80.